Gufic Biosciences Limited — Important, 15-07-2025: General Updates

Gufic Biosciences has increased its stake in subsidiary Gufic Prime Private Limited (GPPL) by acquiring 512,000 equity shares via a Rights Issue for Rs 0.0512 Cr. This move boosts the company's total shareholding in GPPL to 60% (600,000 shares). GPPL is a pharmaceutical marketing and distribution entity with Rs 0.10 Cr paid-up capital, aligning with Gufic's core business. It's important to note GPPL is yet to commence operations and has reported nil turnover, indicating this is a strategic move for future business development.